ATP2B2 and breast cancer: More recent studies have shown that, specifically, PMCA2 remodels [Ca2+]i in breast cancer cells to facilitate continued HER2 biochemical signalling and PMCA2 knock out inhibits the formation of tumours in vivo [234].